Miami – September 9, 2026 -- BioEdge Research Labs has begun publishing batch-specific Certificates of Analysis (COAs) directly on its product pages, allowing laboratory customers to verify identity and purity data for the exact lot they receive rather than relying on aggregated supplier summaries.
Each lot now carries its own matched documentation
Instead of a single certificate applied across multiple production runs, every vial supplied by the Miami-based company is assigned a lot number tied to a corresponding COA, letting researchers cross-check the physical material against its specific record.
Independent labs handle identity and purity testing
The underlying analysis is conducted by a third-party laboratory rather than BioEdge itself, covering identity verification via mass spectrometry, purity assessment via high-performance liquid chromatography, and contaminant screening.
Supplier documentation practices face growing scrutiny in the research materials market
Variation in how suppliers document research-use-only materials has pushed laboratory customers to demand verifiable, batch-level records over generalized quality claims. BioEdge frames its initiative as a response to that shift, positioning matched lot-to-COA verification as a standard check available across its full product line.
All materials sold by BioEdge are designated strictly for laboratory research and in vitro use by qualified scientific professionals. The company states its products are not drugs, supplements, or medical products, and have not been evaluated by the U.S. Food and Drug Administration for diagnostic, therapeutic, or preventative purposes.